Informatietype:: Event
Thema:: Artificial intelligence
Unit:: Healthy Living & Work

Leiden Drug Development Conference 2024

Unlocking the Power of AI in Healthcare and Drug Development. After two successful editions, the 3rd Leiden Drug Development Conference (LDDC-3) is set to ignite innovation and collaboration. Join us on September 19, 2024, as we explore the intersection of artificial intelligence (AI) and life sciences. Leiden Drug Development Conference (LDDC) organised by Leiden University, Janssen and TNO.

Startdatum:: 19 Sep

Time:: 09:00 - 17:00 (CET)
Location:: Haagse Schouwweg 10, Leiden, The Netherlands
Costs:: Free

AI for efficient drug development

The rapid acceleration of AI applications is reshaping industries worldwide. At LDDC-3, we’re dedicating the entire conference to AI’s impact on drug development, manufacturing, and healthcare. Our programme spans the spectrum—from advanced interaction modeling of 3D protein structures to extracting insights from federated patient data. We’ll also address the ethical implications and desired boundaries of AI applications.

Programme

The programme covers a wide spectrum, from advanced interaction modeling of 3D protein structures to extracting relevant insights from federated patient data. We will also address the ethical and practical implications of AI applications.

Leading Scientists and Keynote Speakers

LDDC-3 brings together visionaries from academia and industry. Our keynote speakers, Herman van Vlijmen and Stef van Grieken, will share their expertise on how AI accelerates drug research. Prepare to be inspired by groundbreaking insights.

Sign up for TNO sessions with experts

Our experts will be hosting the following session: session 3. Saskia Lensink and Jildau Bouman about opportunities and challenges of using Large Multi-Modal Models in the health domain. Register now and meet us on September 19, 2024, and be part of LDDC-3—an inspiring convergence of science, innovation, and collaboration. Let’s unlock the potential of AI in healthcare and drug development together.

Connecting Business and Science

LDDC aims to bridge the gap between business and science. Join us to discover how these forces can reinforce each other. Let’s shape the future of life sciences and health together. For more information, please contact TNO business developer Wim van Hartingsveldt.

Contact us

Skip navigation (Contact us)

Wim van Hartingsveldt

Functie:
Business Development Manager
More about Wim
- Standplaats:
  Leiden - Sylviusweg
- Telefoon:
  +31 88 866 17 30
- Email:
  Email Wim
Looking for an expert?
View all experts